Building Cognitive Resilience to Vaccine Misinformation Using AI in Europe

Starting soon · Not applicable

Conditions studied: Healthy

In brief

This multi-country trial evaluates an AI chatbot designed to counter cognitive biases and inoculate parents against vaccine misinformation, embedded within a large survey across five European countries (n=5,000). Scaled from a 2026 single-country study, outcomes compare behavioural and attitudinal responses against standard-of-care materials (e.g., UNICEF infographics) to identify effective, scalable misinformation interventions.

Key facts

Study ID

NCT07551986

Run by

London School of Hygiene and Tropical Medicine

People needed

5000

Starts

2026-04-01

Expected to finish

2026-04-01

Last updated by the study team

2026-05-01

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Parents or caregivers with children under 18 years old in the five target countries (UK, Netherlands, Croatia, Latvia, and Slovakia); and
• Those who have regular access to a digital device and the internet

You may not qualify if…

• Participants who do not meet the inclusion criteria.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.